Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657106 · ClinicalTrials.gov registry record · NA
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
A NA study of Substance Abuse and Opioid-Related Disorders, sponsored by April M Young.
- Active
- Registry status
- NA
- Development phase
- 752
- Enrollment target
- 1
- Study location
NCT05657106: Active NA study of Substance Abuse and Opioid-Related Disorders, sponsored by April M Young.
NCT05657106 is a NA study of Substance Abuse and Opioid-Related Disorders that is active but no longer recruiting, run by April M Young. The registered enrollment target is 752 participants, below the 5,247-participant average among 58 other Substance Abuse trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05657106, a NA study of Substance Abuse and Opioid-Related Disorders, is active but no longer recruiting, sponsored by April M Young.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 752 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness, implementation outcomes, and cost effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis C, and overdose risk behavior in rural Appalachia. The proposed project will take place in two counties in Appalachian Kentucky, an epicenter for the intertwined national crises of injection drug use, overdoses, and hepatitis C.
Primary Outcome
Self-reported recent (past 30-day) frequency of carrying naloxone (continuous)
Conditions Studied
Interventions
- BEHAVIORAL Harm reduction kiosk
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 752 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What the registry record for NCT05657106 still lists
NCT05657106 is an interventional study that assigns participants to a tested intervention. The registered 752 participants enrollment target is mid-sized for trials with a published cap, below the 5,247-participant average among 58 other Substance Abuse trials with a reported enrollment target (86% lower).
The record links to 8 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Harm reduction kiosk is the first listed.
NCT05657106 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05657106 about?
NCT05657106 is a clinical study titled "Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk". This study will test the effectiveness, implementation outcomes, and cost effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis C, and overdose risk behavior in rural Appalachia. The proposed project will take place in two counties in Appalachian Kentucky, an epicent...
What is the current status of trial NCT05657106?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 752 participants. The study started on 2023-03-06. Estimated completion is 2027-07-31.
What conditions does trial NCT05657106 study?
This clinical trial studies the following conditions: Substance Abuse, Opioid-Related Disorders, Sexually Transmitted Diseases, Human Immunodeficiency Virus (HIV), Drug Overdose.
What interventions are being tested in trial NCT05657106?
The interventions under investigation include: Harm reduction kiosk (BEHAVIORAL).
Who is sponsoring clinical trial NCT05657106?
This trial is sponsored by April M Young, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05657106 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05657106's enrollment target sits among peer trials
752 8th of 58 higher than 51 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06559306 · 752 participants · Phase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI